Merck Serono
First oral MS treatment approved in Russia
July 12, 2010Sales and Marketing Cladribine, MS, Merck Serono, Movectro
Regulators in Russia have approved Merck Serono’s cladribine, lining up the drug to be the first oral treatment for multiple …
Trials of cancer vaccine Stimuvax can resume
June 17, 2010Research and Development Merck Serono, Stimuvax, cancer vaccine, vaccines
Merck Serono has been given clearance to resume part of its clinical trials of its cancer vaccine Stimuvax. Trials of …
Erbitux ‘now standard of care’ in KRAS patients
June 3, 2010Sales and Marketing Erbitux, Merck Serono
A new survey suggests Merck Serono’s Erbitux has become a standard of care for KRAS wild-type metastatic colorectal cancer The …
Global MS awareness campaign launched
June 1, 2010Medical Communications MS, Merck Serono
Merck Serono has launched a short film competition as part of a global campaign, Real MS, to raise awareness of …
Trial boost for Merck KGaA’s cladribine
April 19, 2010Research and Development Cladribine, MS, Merck KGaA, Merck Serono
New data from German pharma company Merck suggests its oral multiple sclerosis treatment cladribine has been successful in treating relapsing …
Adverse event halts Merck cancer vaccine trial
March 23, 2010Research and Development Merck KGaA, Merck Serono, Stimuvax, vaccines
Trials of a new vaccine which helps fight cancer have been halted after one patient developed encephalitis, a potentially fatal …
Digital Pharma: Merck Serono expands PKU website
March 16, 2010Medical Communications Kuvan, Merck Serono, PKU
Merck Serono has expanded its European phenylketonuria disease awareness website, adding versions in French and Spanish. The website was originally …
Merck KGaA invests in bioresearch and bioproduction
March 1, 2010Manufacturing and Production, Research and Development Biochemistry, Merck KGaA, Merck Serono, Millipore, laboratory services
Merck KGaA has bought US life sciences company Millipore Corporation in a $7.2 billion deal to expand its chemicals business. …
Merck KGaA posts modest revenue increase
February 24, 20102009 financials, Erbitux, Merck KGaA, Merck Serono, Rebif
German pharma company Merck has posted a modest rise in revenue amidst strong pharma growth. Revenues increased 2.1% to 7.7 …
Cladribine still set to be first oral MS treatment
January 18, 2010Sales and Marketing Cladribine, FTY-720, MS, Merck Serono
Merck Serono’s new oral treatment for multiple sclerosis cladribine is still tipped to reach the market ahead of its rival, …
Cancer Research UK and Merck KGaA to co-develop leukaemia candidate
January 4, 2010Research and Development Merck Serono, leukaemia, oncology
Cancer Research UK and Cancer Research Technology (CRT), the charity’s development and commercialisation arm, are to undertake a phase I …
Merck Serono opens Beijing R&D centre
November 24, 2009Research and Development China, Merck Serono, em
China’s allure for pharma companies continues unabated with Merck Serono’s opening of a research and development centre in Beijing. The …
Digital Pharma: Byte-sized roundup
November 13, 2009Medical Communications Merck Serono, Solvay, Twitter, bing, digi, digital, digital pharma, google
Solvay Pharma has joined the ranks of pharma companies using Twitter, setting up a Russian language account for its Moscow-based …
Digital Pharma: Byte-sized roundup
November 13, 2009Medical Communications FDA, Merck Serono, Solvay, digital pharma, google, social media
Solvay Pharma has joined the ranks of pharma companies using Twitter, setting up a Russian language account for its Moscow-based …
Merck KGaA’s rising revenues fail to lift bottom line
October 27, 2009Sales and Marketing Merck Serono
Revenues up, earnings down: that was the bottom line to Merck KGaA’s financial performance in the three months to the …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
